Hosted on MSN1mon
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, despite some highly positive news. The U.S. Food and Drug Administration (FDA) approved ...
Hosted on MSN1mon
Vertex's Pain Drug: Big Pharma's Next Major Success?
One notable example is the partnership with Zai Lab to develop and commercialize povetacicept in mainland China, Hong Kong, Macau, Taiwan, and Singapore. This collaboration provides Vertex with ...
The Motley Fool28d
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...